Brain sections were postfixed in acetone for 15 minutes on ice and then blocked with 2% bovine serum albumin, 0.1% Triton X-100 (Sigma-Aldrich), and 10% normal donkey serum for 1 hour at RT. The triple immunostaining was performed using chicken anti–tyrosine hydroxylase (TH) (1/800, AB76442; Abcam, Cambridge, UK), rabbit anti-cFOS (cFOS) (1/50, SC52; Santa Cruz Biotechnology, Dallas, Texas, USA), and goat anti-NK1R (1/800, AB61705; Abcam). Other sections were stained with rabbit anti–neuronal nitric oxide synthase (nNOS) (1/200, 4231; Cell Signalling, Danvers, Massachusetts, USA). Secondary detection was performed using Alexa Fluor 594 donkey anti-rabbit IgG (1/1000, A21207; Life Technologies, Carlsbad, California, USA), FITC donkey anti-chicken (1/1000, 703-095-155; Jackson ImmunoResearch, Ely, Cambridgeshire, UK), Alexa Fluor 633 donkey anti-goat (1/1000, A11073; Life Technologies), or Alexa Fluor 488 donkey anti-rabbit IgG (1/1000, A21207; Life Technologies) for 1 hour at RT, diluted in blocking solution. Samples were counterstained with 4,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Inc., Burlingame, CA, USA) and mounted. Pictures were acquired with a DeltaVision Ultra microscope (GE Healthcare, Chicago, IL, USA) (20×). The image analysis was performed using ImageJ software (National Institutes of Health, Bethesda, MD, USA). A negative control using only the secondary antibody was used to establish a fluorescence threshold in each channel. In addition, isotypes control were performed (
Supplementary Material). Then, triple-positive cells (TH
+, cFOS
+, NK1R
+) were quantified and normalized by the total number of TH
+ cells. The result was expressed as triple-positive cell percentage. cFOS
+ or nNOS
+ neurons were quantified separately and the results expressed as nNOS
+ or cFOS
+ cells/section. For the PVH, 10 brain sections and two fields/section were quantified; for the LHA, 20 brain sections and six fields/section were analyzed.